Major US pharmacy push for e-Rxing

4 May 2008

A major marketing campaign to promote electronic prescribing has been launched in the USA by the leading retail pharmacy chains and thousands of independent pharmacists. The aim is to raise public awareness of the potential advantages of e-prescribing and highlight the current bottle-neck in the system: the relatively small number of physicians willing or able to adopt the practice.

A dedicated web site (www.learnabouteprescriptions.com) has been set up to support the campaign, which also involves signs at 26,000 participating outlets, from the biggest specialist chain, Walgreens, and the world's largest retailer, Wal-Mart, to small independent pharmacies.

In a statement to launch the campaign, SureScripts, which administers electronic systems for physicians and drug retailers, claimed that 70% of pharmacies are ready for e-prescribing versus only 6% of physicians.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight